Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.
The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.
Our latest sandpit results in exciting new research projects taking on the challenge of cancer early detection and diagnosis.
New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.
We’ve sent robots to mars, split the atom and mapped the human genome. Why, then, is there still so much more to understand about a disease that affects one in two of us?
To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government’s upcoming 10-Year Cancer Plan.
Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons
A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.
We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels
Together with the National Institute for Health and Care Research, we’re jointly investing £6.4m over the next 14 years in…